American investor Columbia Pacific Management has appointed Morgan Stanley to advise on its sale of Columbia Asia, the portfolio of hospitals in Vietnam, Malaysia, India and Indonesia, with a reported price tag of up to $2bn which we think is ambitious.
UK hospital chain Spire Healthcare's full-year results have confirmed the tough year it warned investors about: revenue was flat, EBITDA fell 26%, while pre-tax profits and EPS were a third and half, respectively, of the previous year. It has slashed its capex in comparison to previous years.
International hospital group Ramsay Health Care saw revenue and EBITDA growth of 14.9% and 9.8%, respectively, in its first financial results since it acquired pan-European acute care operator Capio. Sales are now around 50/50 between Europe and Asia-Pacific, while the weak UK position is becoming clearer.
France's health minister has announced that tariffs to acute hospitals will rise in 2019 for the first time in eight years, and reward quality for the first time ever, while rehab and psychiatry for-profits will be "stable". We talk to LEK's Paris-based co-head of European Healthcare Practice about the news and the for-profit hospital sector's prospects in France generally.
Brazil's largest hospital group by revenue, Rede d'Or, has announced its expansion plans for the next five years. But given ongoing speculation about its plans to list, it seems likely to IPO well within this timeframe, perhaps even this year. HBI puts this to the company and talks to a market expert.
Recently-passed legislation has given South Africa's competition commission more powers to act on its findings in June 2018's health market inquiry, which was highly critical of the country's private healthcare sector.
Margins are improving at Finnish outsourcing specialist Pihlajalinna which had a difficult start to its year, and the oft-delayed SOTE reforms continue to hamper contracts. We speak to an analyst following the company in the wake of the release of its FY results.
Pan-Asian hospital group IHH Healthcare saw 3% revenue growth, 9% EBITDA growth but a 35% plummet in post-tax profits in 2018. The results confirm its struggles in Turkey.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
